The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The neutrophil to lymphocyte ratio as a prognostic factor among a diverse population with advanced pancreatic cancer.
 
Michael Shusterman
No Relationships to Disclose
 
Erin Jou
No Relationships to Disclose
 
Andreas Kaubisch
No Relationships to Disclose
 
Jennifer W. Chuy
No Relationships to Disclose
 
Lakshmi Rajdev
No Relationships to Disclose
 
Justin Tang
No Relationships to Disclose
 
Nitin Ohri
No Relationships to Disclose
 
Santiago Aparo
Speakers' Bureau - Celgene
 
Sanjay Goel
Honoraria - Bayer; Genentech/Roche
Research Funding - Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364